EGFR and lung carcinoma: In this study, we examined the phenotypic and molecular differences between gefitinib -sensitive and -insensitive lung cancer cells with wtEGFR using in vitro and in vivo models and found a potential relationship between gefitinib response and EGFR endocytosis.